Among high-risk human papillomaviruses (HPV), HPV-16 infection is the most prevalent causative factor for cervical cancer. Beside other mucosal targets, HPV-16 was reported to infect the placenta and to replicate in trophoblastic cells. Since these cells share invasive properties of tumoral cells, they represent an ideal model to investigate several oncogenic processes. In the present work, we analyzed the impacts of HPV-16 E5, E6 and E7 oncoproteins on the trophoblastic model. Our results showed that E5 impaired the viability of trophoblastic and cervical cell lines but E6 and E7, favoring cell growth, neutralized the E5 cytotoxic effect. In addition, E5 decreased the adhesiveness of trophoblastic cells to the tissue culture plastic and to endometrial cells similarly as described previously for E6 and E7. E5 and E6 plus E7 increased also their migration and their invasive properties. Cells expressing HPV-16 early proteins under the control of the long control region endogenous promoter displayed growth advantage and were also more motile and invasive compared with control cells. Interestingly, the E-cadherin was downregulated in trophoblastic cells expressing E5, E6 and E7. Nuclear factor-kappaB and activator protein-1 activities were also enhanced. In conclusion, HPV-16 early proteins enhanced trophoblastic growth and intensify the malignant phenotype by impairing cell adhesion leading to increased cellular motile and invasive properties. HPV-16 E5 participated, with E6 and E7, in these changes by impairing E-cadherin expression, a hallmark of malignant progression.
Introduction
Human papillomaviruses (HPVs) are a group of small DNA viruses with epitheliotropic cutaneomucosal tropism. The genital infections are commonly cleared within 2 years but a subset of HPVs termed 'high risk' may persist and in rare cases lead to premalignant lesions and to invasive carcinoma. Infection with HPV-16 is the cause of 50-70% of cervical cancers, the second most frequent cause of death by cancer among females worldwide (reviewed in ref. 1) . The oncogenic effect of HPV-16 is commonly attributed to the E6 and E7 viral proteins that abrogate the cell cycle checkpoints by inactivating tumor suppressors, such as p53 and pRb, respectively, and targeting a plethora of other key host cellular proteins involved in apoptosis and malignant cellular transformation (2) .
Briefly, E6 induces p53 degradation through its association with the cellular protein E6-associated protein via the ubiquitin proteolytic pathway (3) . Several in vitro and in vivo studies reported other E6/ E6-associated protein targets. Among those, PDZ-motif-containing proteins inducing cell polarity loss (4-7), Bak, Fas-associated protein with death domain and procaspase 8 interfering with apoptosis (8, 9) and NFX1 and hTERT contributing to immortalization (10) .
E7 induces the degradation of pRB and its 'pocket' family members via the proteasome pathway thereby releasing the transcription factor E2F that controls numerous cellular processes (11) . One cyclindependent kinase inhibitor, p16, which prevents the phosphorylation of pRb family members, is overexpressed when pRb is inactivated by E7 (12) . E6 and E7 can subvert the immune system by impairing, among others, the expression of adhesion molecules (13) (14) (15) . Deregulation of adhesion molecules is not only a strategy for immune evasion but also a prelude to early carcinogenesis and metastatic processes (16) . E6 and E7 have been reported to cooperate with ErbB-2 in head and neck carcinogenesis by downregulating E-cadherin expression (17) . Extracellular matrix degradation by metalloproteinases is dramatically increased in invasive carcinoma expressing E6 and E7 (18) . All together, these data suggest that E6 and E7 oncoproteins are the main determining factors of the malignant phenotype in HPVinduced cancers.
Recent findings have implicated the HPV-16 E5 protein as an important mediator to oncogenic transformation. The epidermal growth factor receptor is a potential target of E5. The association of E5 with the 16 kDa proton-adenosine triphosphatase subunit could alter the endosomal acidification and lead to a subsequent increase of phosphorylated epidermal growth factor receptor at the cell surface (19, 20) . E5 enhances the immortalization potential of E6 and E7 and stimulates the proliferation in cooperation with E7 (21, 22) . Transgenic mice studies showed that E5 alters the growth and differentiation of stratified epithelia and induces epithelial tumor (23) . E5 confers to cells the property to grow in an anchorage-independent manner (24) . Significant morphological changes of the cells and reorganization of the actin cytoskeleton were attributed to the transforming potential of E5: inducing koilocyte formation in cooperation with E6 (25) ; changing the lipid composition of the membranes (26, 27) ; inhibiting gap junctional intercellular communication (28, 29) and increasing cell motility (30) .
Surprisingly, recent studies reported that HPV could infect the human placenta and that various HPV types could complete their entire life cycle in a trophoblastic cell line (31, 32) . The trophoblast is known to share similar properties with malignant tumoral cells including invasive and migratory capacities (33) . BeWo cells, known as 'trophoblastic-like cells', share many morphologic, metabolic and functional characteristics with trophoblast cells of the normal first trimester placenta (34) . In the present work, we used the BeWo cells as a model to study the effects of HPV-16 E5, E6 andpolymerase chain reaction (PCR) using primers 5#-AAGGCGGCCGCTAT-GACAAATCTTGATACTGC-3# and 5#-ATGCTCTAGACATTATGTAAT-TAAAAAGCG-3#. The two ORF in tandem HPV-16 E6/E7 was amplified using 5#-AGCGCGGCCGCTATGCACCAAAAGAGAACTGC-3# and 5# ATGCTCTAGAGATTATGGTTTCTGAGAACAG-3#. PCR products were first subcloned into the TOPO-TA vector (Invitrogen, Carlsbad, CA) and then inserted into NotI/XbaI restriction site of pEF6-Flag vector. All plasmid constructions were verified by DNA sequencing. pHPV-16-early and pLCR-GFP were kindly provided by C.Weyn (Université Libre de Bruxelles, Belgium). pEF6-LacZ (Invitrogen) was used as a negative control. peGFP-NLS was provided by Dr X.Saelens (VIB, Belgium) and pGL4-Luc-Renilla plasmid was a kind gift of Dr C.Van Lint (Université Libre de Bruxelles, Belgium). pAP-1-Luc and pNF-jB-Luc were kindly provided by Dr Yves Jacob (Pasteur Institute, France).
Cell culture and transfections
BeWo and JEG-3 choriocarcinoma cell lines were kindly offered by Dr A.Pötgens (Aachen, Germany) and Dr R.Pijnenborg (Katholieke Universiteit Leuven, Belgium), respectively. C33a cervical cell lines were purchased from American Type Culture Collection (Rockville, MD). HEC-1A and RL-95 endometrial cell lines were a kind gift from Dr A.Coosmans (Katholieke Universiteit Leuven, Belgium). Cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum, 1 mM L-glutamine, 100 U/ml penicillin and 100 mg/ml streptomycin. For transient transfection experiments, BeWo and JEG-3 cells were transfected in six-well plates (6 Â 10 5 cells per well) using 3 lg DNA according to the manufacturer's protocol (JET-PEI; PolyPlus, Illkirch, France and ExGen 500; Fermentas, Burlington, Canada). C33a cells were transfected using 3 lg DNA by the phosphate calcium method (35) . The transfection efficiency was assessed by transfecting separately or cotransfecting 30 ng of peGFP-NLS and was typically 40-60% for BeWo cells. For stable transfections, cells were transferred (2.5 Â 10 5 cell/ml) 24 h post-transfection into 60 mm Ø dish and incubated for 14 days with blasticidin 6.25 lg/ml (Invitrogen). Due to the lack of sequence coding for the blasticidin resistance in the pHPV-16-early and pLCR-GFP plasmids, both constructs (2.7 lg) were cotransfected in stable transfections with pEF6-LacZ (300 ng).
RNA extraction and quantitative real-time reverse transcription-polymerase chain reaction Transiently transfected cells were washed with CellScrub TM buffer (Genlantis, San Diego, CA) in order to remove the extracellular plasmids. Total cellular RNA was extracted using the Nucleospin RNA II Total RNA extraction kit including DNase-I digestion (Macherey-Nagel, Düren, Germany). An additional stringent DNase-I reaction was performed using TurboDNaseI (Ambion-Applied Biosystems, Austin, TX). First-strand complementary DNAs were generated by reverse transcription from 1 lg of total RNA in a total volume of 20 ll using the RevertAid H Minus First strand cDNA synthesis kit containing random hexamers and H minus M-MuLV Reverse transcriptase (Fermentas). Quantitative expression of the HPV-16E5, HPV-16E6, HPV-16E7 and beta-galactosidase (LacZ) genes was analyzed by real-time PCR using the iCycler iQ system and the iQ Sybr Green Supermix (Bio-Rad Laboratories, Hercules, CA). Complementary DNAs (100 ng) were amplified in 25 ll total volume PCR reaction with specific primers under the following cycle conditions: 95°C for 3 min, followed by 45 cycles of 95°C for 30 s and 59°C for 30 s. Gene expression was normalized using values obtained for the housekeeping GAPDH gene. The primers used for the amplification were GAPDH, 5#-GAAGGTGAAGGTCGGAGTC-3# and 5#-GAAGATGGTGATGGGA-TTTC-3# (36); 16-E5, 5#-CGTCCGCTGCTTTTGTCTGTGTCTACATAC-3# and 5#-CACCTAAACGCAGAGGCTGCTGTTATCCAC-3#; 16-E6, 5#-gggaatccatatgctgtatgtg-3# and 5#-gctgttctaatgttgttcc-3#; 16-E7, 5#-cagctcagaggaggaggatg-3# and 5#-cgcacaaccgaagcgtagagtcacac-3# and beta galactosidase (LacZ); 5#-GCAGCAGTGATGATCCAGAACT-3# and 5#-CGTAGGTCACA-GATGAGCCAATAA-3#. A standard curve was generated for each gene. A dissociation curve was performed after each experiment to confirm that a single product was amplified. The quantification of transfected transcripts (E5, E6, E7 and LacZ) was assessed by calculating the 2 (ÀDCT) where (DC T 5 C T transfected gene À C T Housekeeping gene ).
Western blotting
Various protein extraction protocols were optimized in order to detect and retrieve the viral proteins from distinct sites inside the cells. The wild-type HPV-16 N-terminal flagged E5 protein was detected by western blotting in transiently transfected BeWo cells using the Triton X-114 protocol recommended for hydrophobic membrane associated proteins (37) . Forty-eight hours after transfection, cells were washed twice in ice-cold phosphatebuffered saline (PBS) then lysed during 1 h at 4°C in 500 ll ice-cold Triton X-114 lysis buffer (Triton X-114 1%, Tris-HCl 10 mM pH 7.4, NaCl 150 mM, ethylenediaminetetraacetic acid 1 mM, protease inhibitors from Roche Applied Science, Basel, Switzerland). After centrifugation, supernatants were incubated 3 min at 37°C and centrifuged 1 min at 14 000g for phase separation. The lower detergent phase was re-extracted by adding 10 vol of the Triton X-114 lysis buffer and analyzed. HPV-16 E6 was extracted using the Triton X-100 protocol (38) . Briefly, cells were washed twice in icecold PBS, then extracted with a lysis buffer containing 10 mM Tris-HCl (pH 7.5), 50 mM KCl, 2 mM MgCl 2 , 1% Triton X-100 and protease inhibitors (Roche Applied Science). After incubation on ice, lysates were centrifuged at 14 000g for 10 min at 4°C. All fractions were stored at À80°C and quantified using Bradford reagent. Protein extracts (70 lg total protein per lane) or total lysates were subjected to 12.5% or 10% sodium dodecyl sulfatepolyacrylamide gel electrophoresis and transferred to nitrocellulose membranes. Blocking, antibody incubation steps and washing of the membrane were performed in PBS supplemented with 3% skimmed milk and 0.05% Tween 20. Blots were incubated with the anti-Flag horseradish peroxidaseconjugated antibody (Sigma, St Louis, MO) or with mouse anti-E-Cadherin antibody (BD Biosciences, San Jose, CA). Membranes incubated with primary antibodies were consequently incubated with horseradish peroxidase-conjugated anti-mouse secondary antibodies (GE Healthcare Bio-Sciences, Piscataway, NJ). Blots were incubated with mouse anti-b-actin antibody to control equal loading (MP Biomedicals, Irvine, California). Immunoreactive proteins were visualized using chemiluminescence, captured on hypersensitive film (GE Healthcare Bio-Sciences).
Immunofluorescence confocal microscopy Forty-eight hours after transfection, BeWo and JEG-3 cells were fixed for 5 min with Immunohistofix (Bio-Rad Laboratories) at room temperature followed by 6 min with 100% methanol at À20°C. After two washes with PBS, the samples were saturated for 1 h with PBS containing 0.5% gelatin and 0.25% bovine serum albumin and stained for 1 h with a 1/10 dilution of an anti-Flag mouse monoclonal immunoglobulin G (C-M2, Sigma). The samples were then washed three times with PBS containing 0.2% gelatin and incubated for 1 h with a 1/200 dilution of the secondary antibody: Alexa-488-coupled goat anti-mouse immunoglobulin G (Invitrogen). The samples were then washed three times in PBS with 0.2% gelatin and mounted for analysis on a Zeiss LSM510 laser scanning confocal microscope.
Cell adhesion assay
BeWo cells (6 Â 10 5 ) were transiently cotransfected with 30 ng pGL4-LucRenilla plasmid and 2.77 lg pEF6-Flag-HPV-16 E5 or 2.77 lg pEF6-LacZ as described above. Forty-eight hours post-transfection, cells were detached, resuspended in the medium and counted. BeWo cells (8 Â 10 5 ) from each transfection were lysed in order to assess input luciferase activity. The same number of cells was put in culture with or without RL-95 and HEC-1A endometrial cell lines already attached to the support up to 95% confluence. After 2 h incubation, the attached cells were washed and processed using the Luciferase Assay Kit (Promega, Madison, WI). The percentage of adhesiveness was calculated by normalizing luciferase activity found in the attached cells to the input of luciferase activity.
Cytotoxicity and viability assays
The lactate dehydrogenase release was measured using the Cytotoxicity Detection Kit (Roche Applied Science) in cells' supernatants. Thirty hours after transient transfection or 24 h after media refreshments of stably transfected cell clones, crystal violet staining was used to assess the cellular confluence after stable transfections. Cells were fixed with ice-cold methanol and stained for 15 min with crystal violet solution (0.1%). After three washes, dishes were dried at room temperature. Cell staining was eluted in 1 ml of acetic acid (10%) and measured at 540 nm. In stable transfection, lactate dehydrogenase values were normalized to the crystal coloration so that the cytotoxicity level could not be biased by the cell amount.
Luciferase assay
One hundred nanograms pAP-1-Luc or 50 ng pNF-jB-Luc luciferase reporter plasmids were cotransfected with, respectively, 700 ng of pHPV-16 E5 or 750 ng of pHPV-16 E6/E7 and 30 ng pGL4-Luc-Renilla, into BeWo cells (plated in 24-well plates at 7 Â 10 4 cells per well on the day before). Forty-eight hours after transfection, cells were harvested and luciferase assays were performed according to the protocol of the Dual Luciferase Assay system (Promega). Firefly Luciferase activity was normalized to Renilla Luciferase activity to correct for transcription efficiency in each reaction.
Cell migration and invasion assays
In both migration and invasion assays, 100 ll of BeWo cells (10 6 cells per ml) in Dulbecco's modified Eagle's medium supplemented with 0.1% bovine serum albumin were seeded in the upper compartment of the Boyden chamber.
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The same cell number was seeded in 24-well plate without inserts as an input normalization control. The lower compartment was filled with 600 ll of Dulbecco's modified Eagle's medium and 1% bovine serum albumin supplemented with 10% fetal calf serum. The two compartments were separated by a porous filter (8 lm pore). For invasion assay, the filter was coated using 25 lg of Matrigel (BD Biosciences). The chambers were incubated for 24 h at 37°C, then fixed in ice-cold methanol and stained with crystal violet (0.1%). The cells on the upper surface of the filter were scrapped with a cotton swab. Migration and invasion were quantified by elution of the crystal violet in the lower surface of the filter and in the control wells by adding 50 ll of acetic acid 10% and measuring absorbance at 540 nm. The percentage of migration or invasion was calculated by normalizing absorbance from the lower surface of the filter to the absorbance from the control wells without filter.
Statistics
Results were obtained from at least three independent experiments with using different batches of DNA. Data are presented as means ± SDs of triplicates from a representative experiment. Triplicates from all experiments were averaged before statistical analysis. Student's two-tailed t-test was used for statistical analysis and a P value ,0.05 was considered as statistically significant.
Results

HPV-16 early proteins expression in trophoblastic cells
To analyze the impact of HPV-16 E5, E6 and E7 early proteins on the physiology of trophoblastic cells, we first generated plasmids for the expression of N-terminally flagged E5 or simultaneous expression of both N-terminally flagged E6 and unflagged E7 in tandem under the control of the ubiquitous human elongation factor alpha promoter (hEF-1a). The expression of LacZ, HPV-16 E5, E6 and E7 genes were confirmed in transiently transfected BeWo cells by quantitative real-time reverse transcription-polymerase chain reaction (RT-PCR) ( Figure 1A ). Figure 1B shows that Flag-E5 protein formed monomers (11 kDa), dimers and multimers. In confocal microscopy analysis, HPV-16 E5 was observed in internal membrane compartments of trophoblastic cells ( Figure 1C) , as previously reported in other cell types (24, 39) .
HPV-16 E6 was retrieved from transiently transfected BeWo cells using the Triton X-100 lysis protocol, as described previously (38) and detected by immunoblotting ( Figure 1B) . The 18 kDa band corresponds to the predicted size of HPV-16 E6 (40) . The expression of messenger RNA able to express the unflagged E7 oncogene from the tandem pHPV-16 E6/E7 construction was confirmed by quantitative real-time RT-PCR ( Figure 1A) . These results showed that HPV-16 E5 and E6 are expressed in transfected trophoblastic cells ( Figure 1A) ; moreover, the presence of E7 messenger RNA suggested that the E7 protein could also potentially be expressed in those cells.
The Figure 1A) , not only promoted viability but could also counteract E5 cytotoxic effect. The crystal violet staining showed that the number and the size of E5 colonies were smaller than LacZ, E6/E7 or E5/E6/E7 colonies in both cell types. Moreover, we noticed that expression of the E5 messenger RNA transcripts were not anymore detectable after five passages in stable transfection (data not shown), on the opposite to the expression of the other Figure 2B , pHPV-16-early stably transfected cells exhibited no cytotoxicity, with greater colonies number than Green Fluorescent Protein controls ( Figure 2B ). These results confirmed that physiologically regulated HPV-16 early proteins promote the growth of both trophoblastic and cervical cells.
The AP-1 and nuclear factor-kappaB pathways are stimulated by HPV-16 E5 and E6/E7 oncoproteins According to the viability/cytotoxicity results, we analyzed whether the activity of activator protein-1 (AP-1) and nuclear factor-kappaB (NF-jB) transcription factors was modified in trophoblastic cells expressing either HPV-16 E5 or E6/E7. Compared with LacZ expressing cells, AP-1 activity was 18 and 60 times higher in cells cotransfected with pHPV-16 E5 or pHPV-16 E6/E7, respectively ( Figure 3A) . On the other hand, cotransfection with pHPV-16 E5 induced a 4-fold increase in NF-jB activation, whereas a 3-fold induction was obtained when cotransfecting pHPV-16 E6/E7 ( Figure 3B ). Thus, HPV-16 E5 or E6/E7 might influence cellular growth via differential activation of AP-1 and NF-jB.
HPV-16 E5 affects the adhesion of trophoblastic cells
You et al. (41) reported that HPV-16 E6/E7 enhanced the malignant phenotype of trophoblastic cells and reduced their adhesion to endometrial cells. Little is known concerning HPV-16 E5 involvement in malignant phenotype and its ability to alter adhesion capacities. In the present work, we analyzed the effect of HPV-16 E5 on the adhesiveness of BeWo trophoblastic-like cells to the tissue culture plastic and to the RL-95 and HEC-1A endometrial-like cells, a model mimicking trophoblast cells attachment to the endometrial bed. As shown in Figure 4 , BeWo cells transfected with pHPV-16E5 were less prone to attach to the plastic substrate or to the RL-95 and HEC-1A endometrial-like cells, compared with LacZ control. These results suggest that HPV-16 E5 reduces adhesiveness of trophoblastic cells to the tissue culture plastic and to endometrial cells. HPV-16 E5, like E6 and E7, affects trophoblast adhesion.
HPV-16 E5 and E6/E7 increase chemotaxic and invasive properties of trophoblastic cells
In regards to the impact of the HPV-16 E5 on BeWo cells adhesion, we analyzed the effect of HPV-16 E5 or E6/E7 expression on BeWo cells motility and invasiveness. Compared with the pEF6-LacZ transfected control, pHPV-16E5 transfected cells migrated and invaded slightly more efficiently, whereas E6/E7 transfected cells migrated and invaded even up to two times more easily ( Figure 5A and B) . Similar results were observed with stably transfected BeWo cells (data not shown). Thus, E5, like E6/E7 is able to increase the trophoblast malignant phenotype by triggering cellular migration and invasion.
When HPV-16 early proteins were expressed under the control of the viral LCR (pHPV-16-early), cell migration and invasion were also significantly enhanced compared with control cells (Figure 5C and D) . The number of cells colonies obtained by transfecting pHPV-16-early or pLCR-GFP was lower as the plasmid allowing blasticidin resistance was cotransfected in a ratio 1 for 10. The expression of HPV-16 E5, E6 and E7 under the control of the endogenous original promoter (LCR) or an ubiquitous promoter (elongation factor 1a) increases motile and invasive properties of trophoblastic cells. 
The trophoblastic cells expressing HPV-16 E5, E6/E7 and E5/E6/E7 have defective expression of E-cadherin
Several reports showed that the cell-cell adhesion molecule Ecadherin expression is altered during HPV carcinogenesis. Therefore, the expression of the E-cadherin protein was analyzed by western blotting in total lysates of BeWo cells transiently or stably transfected with pEF6-LacZ, pHPV-16 E5 and pHPV-16 E6/E7 or cotransfected with pHPV-16 E5 and pHPV-16 E6/E7 plasmids. Interestingly, the E-cadherin expression was decreased not only in BeWo cells expressing HPV-16 E6/E7 but also in BeWo cells expressing HPV-16 E5 (tested alone or in the concomitant presence of HPV-16 E6 and E7; Figure 6A and B). These data suggest that the HPV-16 E5, E6 and E7 downregulate E-cadherin protein expression in trophoblastic cells.
Discussion
The involvement of E5, E6 and E7 oncoproteins in each stage of the multi-step carcinogenesis remains poorly understood and the list of new HPV tissue tropism is still lengthening (reviewed in ref. 1). Recently, our group and others revealed that multiple types of HPV could infect and replicate in human trophoblastic cells (31, 32) . In the present study, we explored the impacts of HPV-16 E5 and E6/E7 on human trophoblastic cell lines. The trophoblast represents a suitable model to study tumorigenesis since it behaves in a way similar to malignant tumoral cells but obeys to rigorous spatial-temporal regulation of growth, migration and invasion during the different stages of pregnancy. BeWo cells, baptized 'trophoblastic-like cells' share many morphologic, metabolic and functional characteristics with primary human trophoblasts of the normal first trimester placenta (34, 42) . The aim of this study was to evaluate the effects of HPV-16 E5, E6 and E7 oncoproteins on human trophoblasts and to identify new molecular targets.
We showed that HPV-16 E5 and E6/E7 genes products can be expressed in BeWo transfected cells. The flagged HPV-16 E6 protein was shown to be properly expressed from the E6/E7 ORF and the expression of the non-flagged E7 was confirmed by quantitative realtime RT-PCR. It is known that detection of the small hydrophobic E5 protein is not easy since a considerable proportion of codons within the HPV 16 E5 ORF are inefficiently translated in human cells (43) . Many groups used SV40 transformed cell lines, optimized E5 codons or the Tet-off systems for E5 overexpression (19, 43, 44) . As observed on western blot, in a multimerized profile, the wild-type flagged HPV-16 E5 protein was expressed in BeWo cells. The persistence of multimers under reducing conditions could be attributed to the huge amount of the hydrophobic E5 protein concentrated in the detergent phase during the extraction procedure, favoring protein aggregation (45) . Meanwhile, the localization of this protein was observed in internal cell membranes, as previously reported (45) .
We observed that expression of HPV-16 E5 induced a cytotoxic effect on transfected cells. On the contrary, the expression of HPV-16 E6/E7 did not cause any cytotoxicity and could abrogate the E5 induced cytotoxicity, even though coexpression of E6 and E7 was at least four times lower than the expression of E5, according to the quantitative real-time RT-PCR data. Similar results were observed after stable transfections or transient transfections, on two choriocarcinoma cell lines and on one cervical cell line. These observations suggest that an extended HPV-16 E5 expression alters cell viability.
Although HPV-16 E5 was reported to induce proliferation (46) , an extended HPV-16 E5 expression was reported to be lethal in various cell lines (44, 47) . Kabsch et al. (48) observed that HPV-16 E5 protein sensitizes human keratinocytes and mouse fibroblasts to apoptosis induced by osmotic stress. In contrast, the same group showed that E5 expressing cells were less sensitive to Fas-and tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis (9). Bravo et al. (26) also discussed a putative correlation between the E5-altered lipid composition in keratinocytes membranes and apoptosis. Kivi et al. (30) observed that microarray analysis could only be performed within the first 24 h since prolonged expression would be lethal to HaCat cells. Codon optimized HPV-16 E5 expression also reduced in vitro life span of keratinocytes (24, 43) . Furthermore, several studies reported that E5 expression is usually transient during HPV productive cycle, weak, restricted to undifferentiated cells and that the E5 ORF is often deleted when HPV DNA is integrated (49, 50) . HPV-16 E6/E7 proteins are known to be the major oncoproteins and the most relevant to malignant progression of HPV-transformed cells. In the 
Effects of oncoproteins on trophoblastic cells
present work, we demonstrated that HPV-16 E6/E7 were not only able to maintain and enhance cell growth for long-term expression in both stably transfected trophoblastic and cervical cell lines but also to reduce E5 cytotoxicity. The positive effect of HPV-16 E6/E7 on trophoblastic cell growth confirmed previous reports (41) but is in discrepancy with the study by Gomez et al. (41) . This latter group transfected a SV40 T antigen immortalized trophoblastic cell line with the complete HPV-16 genome. Surprisingly, on the opposite to many studies and unexpected for a non-lytic virus, they observed a strong reduction of cell viability in the selected transfected cells and a reduced invasive phenotype. Although they detected HPV DNA sequences and L1 protein expression only 7 and 15 days after transfection, respectively, they did not study early proteins expression that makes interpretation uneasy.
It is difficult to assess which molecular signals could be involved in the growth advantage induced by HPV-16 early proteins, especially in trophoblastic cells because those cells are able to produce virtually all cytokines (51). As we detected a higher transcriptional activity of the AP-1 family transcriptional factors when cotransfecting pHPV-16E5 or even more when cotransfecting pHPV-16 E6/E7, it is possible that AP-1 activation could play a role in association with other signaling pathways. Meanwhile, the transcriptional activity of NF-jB was significantly higher in cells expressing HPV-16 E5 than those expressing E6/E7, suggesting that AP-1/NF-jB balance could be important to promote viability.
Previous reports showed that HPV-16 E6/E7 decreases the trophoblast attachment to endometrial cells and might alter trophoblast implantation (41) . In the present report, we showed that HPV-16 E5 affects trophoblast adhesion to tissue culture substrate and to endometrial cells. Data reporting the impact of E5 on cell adhesion are relatively scarce. E5 was reported to alter adhesion signaling (30) and to impair gap junction-mediated cell-cell communication by dephosphorylating (28) or downregulating connexin 43 (29) . It is well known that the major oncoproteins E6/E7 affect adhesiveness of several cell types and enhance their malignant phenotype (reviewed in ref. 52 ). The defect in adhesiveness of trophoblastic cells expressing HPV-16 E5 suggests that E5, like E6/E7 might contribute to malignancy and lead to potential abnormal implantation of the early embryo because of trophoblasts inappropriate spreading.
Subsequently, according to the lower attachment of E5 or E6/E7 transfected cells to various supports, we observed that HPV-16 E5 and in a larger measure E6/E7 enhance the trophoblast motility and invasiveness through the extracellular matrix. The expression of either HPV-16 E6 or E7, separately, gave similar results as E6/E7 expressed in tandem (data not shown).
E-cadherin impairment represents the hallmark of malignancy and is strongly associated to a poor prognostic for many tumors (53) . It is not only affecting cell-cell adhesion but also cytoskeleton rearrangement, cell adhesion to the extracellular matrix and subsequently migration and invasion (15) . E-cadherin is a Ca 2þ -dependent cell-cell adhesion molecule connecting cells by direct E-cadherin contact with one another. The cytoplasmic interactions of this transmembrane molecule with the cytoskeleton is believed to be essential in conferring appropriate mechanical properties to cell-cell adhesion (54) . In the present work, we noticed a significant E-cadherin protein downregulation not only in trophoblastic cells expressing HPV-16 E6 or E7, separately (data not shown) or in tandem, but also in cells expressing HPV-16 E5 alone or in presence of HPV-16 E6/E7. Our results are in agreement with previous publications, reporting that E6 (15) and E7 (14) could reduce E-cadherin expression. It is tempting to suggest that the reduction of adhesion of the BeWo cells expressing HPV-16 E5 on endometrial cells could be, at least partly, due to the E-cadherin downregulation. However, the reduction of adhesion of these cells to the plastic flask might involve other mechanisms.
The transition from epithelial and adhesive cells to mesenchymal and motile cells is an important step during development and tumor progression. A key event in this process is the functional loss of Ecadherin. The NF-jB signaling pathway has also been reported to be a critical mediator of this transition. A direct link between the loss of the E-cadherin expression and the activation of NF-jB activity was reported by different groups (55, 56) . The induction of snail transcription factor, an inhibitor of the E-cadherin gene transcription, could be one of the signaling mediators between these two observations (57, 58) .
It is worth noting that lack of cell adhesion to matrix has in most non-transformed cells an adverse effect on cell survival, inducing a specific type of apoptosis, known as anoikis. Disruption of E-cadherin is mainly associated with this process. However, activation of AP-1 and NF-jB transcriptional activities have been involved in the acquisition of anoikis resistance during the epithelial mesenchymal transition process (59) . We speculate that partly because of a differential NF-jB versus AP-1 activation balance, E5 could be less favorable to cell survival compared with E6 and E7. Our results and a recent publication suggest (60) that the activation of both NF-jB and AP-1 by HPV-16 E5 might contribute to carcinogenesis.
In conclusion, our results showed that HPV-16 oncoproteins alter the main human trophoblast functions by affecting its growth and adhesion and by increasing its migratory and invasive properties. The downregulation of E-cadherin expression in trophoblastic cells by the HPV-16 E5, E6 and E7 early proteins could at least partially explain their reduced adhesiveness and subsequently enhanced migratory abilities. 
